Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans
The purpose of this study is to characterize the interactive effects of acute intravenous (IV) alcohol and nicotine administration in male and female smokers and nonsmokers who use alcohol...
Brief Summary
Official Title: “Interactive Psychopharmacologic Effects of Alcohol and Nicotine in Humans”
The purpose of this study is to characterize the interactive effects of acute intravenous (IV) alcohol and nicotine administration in male and female smokers and nonsmokers who use alcohol.
- Study Type: Interventional
- Study Design: Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)
- Study Primary Completion Date: December 2011
Intervention(s) in this Clinical Trial
- Drug: Nicotine
- 1.0 microg/kg/min IV x 10 minutes
- Drug: Ethanol
- IV
Arms, Groups and Cohorts in this Clinical Trial
- Experimental: 1
- Three test days, within-subject design.
Outcome Measures for this Clinical Trial
Primary Measures
- Behavioral and Cognitive Measures
- Time Frame: Baseline and Test Day
Safety Issue?: No
- Time Frame: Baseline and Test Day
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Male or Female, 21 to 50 years old.
Exclusion Criteria:
- Alcohol or Nicotine Naive
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 21 Years
Maximum Age for this Clinical Trial: 50 Years
Are Healthy Volunteers Accepted for this Clinical Trial?: Accepts Healthy Volunteers
Clinical Trial Investigator Information
Lead Investigator: Yale University Other
Overall Clinical Trial Officials and Contacts
Deepak C D'Souza, M.D. Principal Investigator Yale University
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00616746
Study ID Number: 0607001614
ClinicalTrials.gov Identifier: NCT00616746
Health Authority: United States: Food and Drug Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00616746
